Financhill
Back

AtriCure 10K Form

Sell
20

ATRC
AtriCure

Last Price:
41.06
Seasonality Move:
1.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATRC News And Ratings

See the #1 stock for the next 7 days that we like better than ATRC

ATRC Financial Statistics

Sales & Book Value

Annual Sales: $330.38M
Cash Flow: $-30.07M
Price / Cash Flow: 0
Annual Sales: $9.77
Price / Book: 4.21

Profitability

EPS (TTM): -0.61000
Net Income (TTM): $-28.04M
Gross Margin: $245.94M
Return on Equity: -6.15%
Return on Assets: -4.78%

AtriCure Earnings Forecast

Key AtriCure Financial Ratios

  • The Gross Profit Margin over the past 22 years for ATRC is 74.44%.
  • The Selling, General & Administrative Expenses for ATRC have been equal to 70.00% of Gross Profit Margin.
  • The Research & Development expenses have been 17.36% of Revenue.
  • The Interest Expense is -10.74% of Operating Income.
  • The Net Earning history of ATRC is -14.07% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 9 years.

AtriCure Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Instruments & Supplies
Sector: Healthcare
Current Symbol: ATRC
CUSIP: 04963C
Website: atricure.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 3.33
Quick Ratio: 2.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATRC Technical Analysis vs Fundamental Analysis

Sell
20
AtriCure (ATRC) is a Sell

Is AtriCure a Buy or a Sell?

  • AtriCure stock is rated a Sell
    The current AtriCure [ATRC] share price is $41.12. The Score for ATRC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.